FPT Launches MediSight AI Framework to Advance Digital Transformation Across Healthcare and Life Sciences
Global technology corporation FPT has introduced MediSight, a comprehensive artificial intelligence (AI)-powered framework developed to help healthcare providers, pharmaceutical companies, and medical device manufacturers accelerate digital transformation while improving operational efficiency, regulatory compliance, and clinical decision-making. The new platform is designed to address many of the healthcare industry’s most pressing challenges by transforming fragmented healthcare information into actionable intelligence through advanced AI technologies.
As healthcare organizations continue to generate enormous volumes of clinical, operational, and administrative data, the need for intelligent systems capable of organizing, analyzing, and extracting meaningful insights has become increasingly important. MediSight aims to bridge this gap by combining autonomous AI agents, specialized healthcare applications, and AI-enhanced engineering capabilities into a unified ecosystem that supports organizations throughout the healthcare value chain.
The launch represents another milestone in FPT’s growing investment in healthcare technology and demonstrates the company’s commitment to helping healthcare organizations embrace AI-driven innovation while maintaining strict regulatory and security standards.
Addressing Healthcare’s Growing Digital Challenges
Healthcare organizations today face a unique combination of opportunities and obstacles. While digital technologies have transformed patient care, hospitals, pharmaceutical companies, and medical device manufacturers often struggle with disconnected systems, fragmented datasets, manual workflows, and increasingly complex compliance requirements.
Clinical teams frequently spend significant amounts of time managing documentation rather than focusing on patient care. Administrative staff handle repetitive operational tasks that can delay service delivery, while researchers and pharmaceutical organizations must navigate extensive regulatory processes during drug development and clinical trials.
At the same time, healthcare data continues to expand at an unprecedented pace. Electronic health records, medical imaging, laboratory results, wearable device information, insurance claims, genomic data, and research databases all contribute to an increasingly complex information landscape.
FPT developed MediSight to help organizations transform these challenges into opportunities by creating a unified AI-powered environment that enables healthcare professionals to extract greater value from their data while reducing administrative burdens and accelerating innovation.
Built on FPT’s AI-First Technology Ecosystem
MediSight is built upon FleziPT, FPT’s AI-first ecosystem that provides the technological foundation for developing and deploying enterprise AI solutions. The framework also follows the company’s CASAN methodology, which helps organizations transition from isolated AI experiments toward fully AI-native operations across business functions.
Rather than implementing AI as a collection of standalone tools, MediSight provides an integrated framework that allows healthcare organizations to embed artificial intelligence throughout clinical operations, regulatory workflows, research activities, and business processes.
This approach enables organizations to scale AI adoption systematically while maintaining governance, transparency, and regulatory compliance.
By integrating intelligent automation with healthcare-specific applications, MediSight helps organizations convert large volumes of disconnected healthcare information into structured, actionable knowledge that supports faster and more informed decision-making.
Three Core Layers Form the Foundation
The MediSight framework is organized into three primary technology layers, each designed to address different aspects of healthcare operations while working together as a unified platform.
Healthcare Insight Platform (HIP)
At the foundation of MediSight is the Healthcare Insight Platform (HIP), which serves as a cloud-native data infrastructure capable of integrating healthcare information from multiple sources.
Healthcare organizations often operate numerous systems that store patient records, laboratory data, imaging files, billing information, and administrative records separately. HIP provides interoperability between these systems using widely adopted healthcare standards including:
- HL7 v2
- Clinical Document Architecture (CDA)
- Fast Healthcare Interoperability Resources (FHIR)
- Digital Imaging and Communications in Medicine (DICOM)
These interoperability capabilities allow healthcare organizations to consolidate data while preserving compatibility with existing electronic health record systems and clinical applications.
HIP also includes advanced data management features such as:
- Automated data mapping
- Clinical terminology standardization
- Data de-identification
- Structured healthcare data transformation
- Improved data governance
These capabilities ensure that organizations can maintain data consistency while supporting analytics, AI models, regulatory reporting, and clinical decision support.
Autonomous AI with MediSight Crew
The second layer, known as MediSight Crew, introduces autonomous AI agents and digital workers specifically developed for healthcare environments.
Unlike conventional automation tools that execute predefined workflows, these AI agents are designed to perform more sophisticated tasks by understanding context, processing medical information, and assisting healthcare professionals across multiple functions.
MediSight Crew supports activities such as:
- Administrative workflow automation
- Clinical documentation assistance
- Regulatory compliance support
- Medical record organization
- Patient communication
- Operational coordination
These intelligent assistants reduce repetitive manual work, allowing clinicians and healthcare staff to spend more time on patient care and strategic decision-making.
For healthcare administrators, autonomous AI workers can streamline routine operational processes while improving accuracy and reducing processing times.
Expanding Healthcare Applications with MediSight Verse
The third layer, MediSight Verse, provides a growing portfolio of healthcare-focused applications that address a wide range of clinical and operational requirements.
These applications support areas including:
- Clinic and hospital management
- Insurance claims administration
- Virtual healthcare services
- Patient engagement platforms
- Clinical trial management
- Medical imaging workflows
- Clinical documentation
- Healthcare analytics
- Performance reporting
Because these applications are built within the same AI-powered framework, organizations can integrate multiple functions without relying on disconnected software systems.
The result is improved operational visibility, more efficient collaboration, and enhanced decision-making across healthcare organizations.
Accelerating Clinical Decision-Making
One of MediSight’s primary objectives is improving the speed and quality of clinical decision-making.
Healthcare professionals routinely review extensive volumes of patient records, diagnostic reports, laboratory results, and imaging studies before making treatment decisions. AI-powered systems can help organize this information into structured summaries while highlighting relevant clinical insights.
Rather than replacing clinicians, MediSight functions as an intelligent decision-support platform that reduces information overload and helps healthcare professionals access critical data more efficiently.
By organizing fragmented information into structured intelligence, clinicians can spend less time searching for information and more time evaluating treatment options and delivering patient care.
Supporting Pharmaceutical Innovation
The framework is also designed to assist pharmaceutical organizations throughout research, development, and commercialization activities.
Drug development involves extensive documentation, regulatory submissions, clinical trial management, and ongoing compliance monitoring. AI technologies can significantly reduce manual workloads by automating documentation processes, organizing research data, and supporting regulatory workflows.
MediSight’s AI-powered capabilities help pharmaceutical companies accelerate development timelines while maintaining compliance with regulatory requirements.
Researchers can also leverage AI-driven analytics to identify patterns within clinical datasets, supporting faster evidence generation and more informed scientific decision-making.
Enhancing Medical Device Development
Medical device manufacturers operate within highly regulated environments where software quality, documentation accuracy, and regulatory compliance are critical.
MediSight supports product development by integrating AI-assisted engineering capabilities into medical software development processes.
The platform helps development teams:
- Streamline documentation
- Improve traceability
- Support regulatory submissions
- Enhance software quality
- Accelerate development cycles
- Reduce manual engineering tasks
These capabilities can shorten time-to-market while maintaining the quality standards required for medical technologies.
Designed for Highly Regulated Healthcare Environments
Healthcare organizations must comply with some of the world’s strictest security and privacy regulations.
MediSight has been designed with healthcare-grade security features that support compliance with major industry standards, including:
- HIPAA
- HITRUST r2
- ISO 27001
The platform emphasizes secure handling of patient information, robust data governance, and comprehensive traceability across healthcare workflows.
Organizations can also deploy the framework across major cloud environments while integrating it with existing healthcare systems, providing flexibility without sacrificing security or compliance.
Improving Operational Efficiency
Beyond clinical applications, MediSight addresses operational efficiency across healthcare organizations.
Administrative inefficiencies remain one of the largest cost drivers within healthcare systems. Manual claims processing, repetitive documentation, fragmented communication, and disconnected workflows often slow operations while increasing administrative expenses.
By introducing autonomous AI workers and workflow automation, MediSight helps organizations:
- Reduce manual data entry
- Streamline administrative processes
- Improve documentation quality
- Enhance compliance monitoring
- Increase operational transparency
- Accelerate decision-making
These improvements can contribute to both cost savings and improved patient experiences.
Leadership Perspective on AI-Powered Healthcare
According to Chu Canh Chieu, Vice President of FPT Software and Head of Healthcare and Life Sciences at FPT Corporation, the healthcare industry is entering a new phase where AI systems must move beyond simply storing information toward actively interpreting and reasoning through healthcare data.
He explained that MediSight has been developed to help healthcare organizations reduce manual workloads, improve the speed of decision-making, and expand digital health capabilities through autonomous AI agents combined with specialized healthcare applications.
He also emphasized that the framework enables digital health providers and pharmaceutical organizations to reduce development timelines for medical software while supporting better patient outcomes without compromising regulatory compliance.
This vision reflects the industry’s broader transition toward intelligent healthcare platforms capable of supporting clinicians, researchers, administrators, and regulators through advanced AI technologies.
Strengthening FPT’s Healthcare Portfolio
The launch of MediSight further expands FPT’s healthcare and life sciences technology portfolio, building upon nearly twenty years of experience serving healthcare organizations worldwide.
During this time, the company has collaborated with hospitals, healthcare providers, pharmaceutical companies, and medical device manufacturers to improve operational efficiency, modernize digital infrastructure, and support patient-centered care initiatives.
FPT has also achieved numerous healthcare certifications and quality standards that reinforce its ability to deliver solutions for highly regulated industries.
These include:
- HITRUST r2
- HIPAA compliance
- ISO 9001
- ISO 13485
- IEC 62304
- HL7
- DICOM
These certifications demonstrate the company’s commitment to maintaining rigorous quality, security, and software engineering standards while delivering enterprise healthcare solutions.
Advancing the Future of AI in Healthcare
Artificial intelligence is increasingly becoming a central component of healthcare transformation, enabling organizations to improve efficiency, enhance clinical outcomes, accelerate research, and strengthen regulatory compliance.
With the introduction of MediSight, FPT is positioning itself as a provider of integrated AI solutions that address the complex needs of healthcare providers, pharmaceutical companies, and medical device manufacturers through a single, scalable framework.
By combining interoperable data infrastructure, autonomous AI agents, healthcare-specific applications, and AI-powered engineering capabilities, MediSight provides organizations with the tools needed to modernize healthcare operations while maintaining high standards of security, governance, and compliance.
As healthcare continues its digital evolution, platforms like MediSight are expected to play an increasingly important role in helping organizations transform vast amounts of healthcare data into meaningful intelligence that supports better patient care, faster innovation, and more efficient healthcare delivery across the global healthcare ecosystem.
Source link: https://www.businesswire.com/
